ATHA Made Headway

Wed, Nov 04, 2020 at 05:30 PM

ATHA (ATHA:NASDAQ) rocketted at $24.69, representing a gain of 24.1%. The stock got featured on our News Catalysts scanner on Fri 23 Oct 20 at 06:01 AM in the 'INVESTOR UPDATE' category. From Tue 20 Oct 20, the stock recorded 40.00% Up Days and 36.36% Green Days

The share price of the company has been moving sideways in recent weeks.

About ATHA (ATHA:NASDAQ)

Athira Pharma Inc is a bio-technology company focused on developing small molecules to restore neuronal health and stop neurodegeneration.

Top 10 Gainers:

Aptevo Therapeutics Inc. (APVO:NASDAQ), 51.2%
Biogen Inc. (BIIB:NASDAQ), 43.97%
Cassava Sciences, Inc. (SAVA:NASDAQ), 25.57%
ATHA (ATHA:NASDAQ), 24.13%
ATHA (ATHA:NYSE), 24.13%
Supernus Pharmaceuticals, Inc. (SUPN:NASDAQ), 23.8%
XPEV (XPEV:NYSE), 23.32%
Prothena Corporation plc (PRTA:NASDAQ), 22.71%
THRY (THRY:NASDAQ), 18.87%
Kandi Technologies Group, Inc. (KNDI:NASDAQ), 18.64%